ARTICLE | Financial News
Audentes Therapeutics amends IPO
July 18, 2016 7:00 AM UTC
Audentes Therapeutics Inc., San Francisco, Calif. Business: Gene/Cell therapy, Cardiovascular, Endocrine/Metabolic Date announced: 2016-07-11 Type: IPO To be raised: Up to $80 million Shares: 5 millio...